Monthly Prescribing Reference42m
Sotatercept Trial Ends Due to Positive Clinical Program Efficacy Data
A phase 3 trial evaluating sotatercept-csrk (Winrevair™) in adults with pulmonary arterial hypertension (PAH; World Health Organization Group 1) ...
Managed Healthcare Executive49m
Another Trial of Winrevair Stopped Early Due to Positive Efficacy
The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.